A comparative study of 2 new phosphate binders (sevelamer and lanthanum carbonate) in routine clinical practice.

Abstract:

INTRODUCTION:Lack of adherence may influence the efficiency of phosphate binders. Our clinical hypothesis was that if lanthanum carbonate (LC) might offer some advantage over sevelamer (S), that that would be in those patients in whom serum phosphate (P) levels were not controlled by S or in those requiring high doses of it, presuming that therapeutic compliance with S could be inadequate. The aim of this study was to compare the cost-consequences of changing from S to LC. METHODS:This was a prospective comparative before-after interventional study. Fifty-one hemodialysis patients prescribed a large number of tablets of S (≥ 9 tablets/day) and/or had serum phosphorus (P) levels >5.5 mg/dL were changed from S to LC; 68 patients who did not meet those criteria served as controls. RESULTS:Mean daily number of total phosphate binder tablets was reduced after the introduction of LC (13.9 ± 5.5 at time 0 vs. 7.7 ± 4.6 at 12 months; p<0.001). LC was suspended in 14 patients (31.1%), due to a wish to return to the previous medication (S). Percentage compliance with the objectives recommended by the NFK-KDOQI guidelines improved after the change (patients with P <5.5 mg/dL: 46.9% at month 0 and 72.5% at month 12; p<0.01). The incremental cost of changing from S (month 0) to LC (month 12) was -107.8 monthly, considering only the costs of phosphate binders. LC reached the P objective at a lower cost (euro 582.2 vs. euro 1,038.5; -44%; p<0.01). CONCLUSIONS:A complete change from S to LC in these particular kinds of patients significantly decreased the cost of treatment while also improving the achievement of NFK-KDOQI guideline objectives for mineral metabolism.

journal_name

J Nephrol

journal_title

Journal of nephrology

authors

Arenas MD,Rebollo P,Malek T,Moledous A,Gil MT,Alvarez-Ude F,Morales A,Cotilla E

subject

Has Abstract

pub_date

2010-11-01 00:00:00

pages

683-92

issue

6

eissn

1121-8428

issn

1724-6059

pii

3E495315-AB0A-44EA-A9F9-174AB3FEC8E5

journal_volume

23

pub_type

杂志文章
  • Association of physical activity with mortality in chronic kidney disease.

    abstract:BACKGROUND:Chronic kidney disease (CKD) is an important risk factor for all-cause mortality. In the general population, physical activity is associated with reduced mortality. We examined the association of level of physical activity with mortality in patients with predominantly nondiabetic CKD stage 3-4. METHODS:We s...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:

    authors: Chen JL,Lerner D,Ruthazer R,Castaneda-Sceppa C,Levey AS

    更新日期:2008-03-01 00:00:00

  • The peritoneal sieving of sodium: a simple and powerful test to rule out the onset of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis.

    abstract:BACKGROUND AND AIMS:Encapsulating peritoneal sclerosis (EPS) is an uncommon but severe complication of peritoneal dialysis (PD). A reliable screening tool to identify patients at risk of developing or not EPS is currently not available. We aimed to evaluate whether the reduction in dialysate sodium concentration (sodiu...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-016-0371-9

    authors: La Milia V,Longhi S,Sironi E,Pontoriero G

    更新日期:2018-02-01 00:00:00

  • Rapidly progressive glomerulonephritis: current and evolving treatment strategies.

    abstract::Rapidly progressive glomerulonephritis (RPGN) must be diagnosed and treated quickly to prevent irreversible organ injury. The commonest cause of RPGN is anti-neutrophil cytoplasm antibody (ANCA) associated small vessel vasculitis, and the most severe is anti-glomerular basement membrane (GBM) antibody disease. In this...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Little MA,Pusey CD

    更新日期:2004-11-01 00:00:00

  • Lipids, blood pressure and bone metabolism after growth hormone therapy in elderly hemodialysis patients.

    abstract:BACKGROUND:Previously we have demonstrated anabolic effects and improved functional status after growth hormone (GH)-therapy in elderly patients in chronic hemodialysis. The aim of this study is to elucidate the effects of GH-therapy on lipid profiles, blood pressure and bone metabolism. METHODS:Twenty patients, mean ...

    journal_title:Journal of nephrology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Viidas U,Johannsson G,Mattson-Hultén L,Ahlmén J

    更新日期:2003-03-01 00:00:00

  • Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis.

    abstract:BACKGROUND:Chronic kidney disease (CKD) progression is associated with significant comorbidities and costs. In Italy, limited evidence of healthcare resource consumption and costs is available. We therefore aimed to investigate the direct healthcare costs in charge to the Lombardy Regional Health Service (RHS) for the ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-016-0291-8

    authors: Roggeri A,Roggeri DP,Zocchetti C,Bersani M,Conte F,ReNe (Renal Lombardy Network).,Additional contributors from ReNe Network.

    更新日期:2017-04-01 00:00:00

  • IgA nephropathy and infections.

    abstract::In this paper we concentrate on the role of infections in IgA nephropathy both from a pathogenetic and clinic point of view. The current hypotheses as regards the role of infections in the pathogenesis of IgA nephropathy are: (a) role of particular pathogens, (b) chronic exposure to mucosal infections, (c) abnormal ha...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-016-0265-x

    authors: Rollino C,Vischini G,Coppo R

    更新日期:2016-08-01 00:00:00

  • Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis.

    abstract:INTRODUCTION:End stage renal disease (ESRD) is associated with a high incidence of cardiovascular disease and cancer. Patients undergoing hemodialysis show a reduced number and an impaired function of endothelial progenitor cells (EPCs), which in physiological conditions contribute to repair the vascular damage. In pat...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Buemi M,Costa C,Floccari F,Coppolino G,Campo S,Bolignano D,Sturiale A,Lacquaniti A,Buemi A,Loddo S,Teti D

    更新日期:2010-05-01 00:00:00

  • Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population.

    abstract:OBJECTIVES:HERMEX is a population-based study which tries to evaluate the relative weight of cardiovascular risk factors in inhabitants of Extremadura, Spain. This report presents the data about chronic kidney disease (CKD) in a Spanish population sample. METHODS:For an observational cross-sectional population-based s...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.5301/jn.5000221

    authors: Robles NR,Felix FJ,Fernandez-Berges D,Perez-Castán JF,Zaro MJ,Lozano L,Alvarez-Palacios P,Garcia-Trigo A,Tejero V,Morcillo Y,Hidalgo AB

    更新日期:2013-07-01 00:00:00

  • Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations.

    abstract::Diabetic kidney disease (DKD) affects approximately one-third of patients with diabetes and taking into consideration the high cardiovascular risk burden associated to this condition a multifactorial therapeutic approach is traditionally recommended, in which glucose and blood pressure control play a central role. The...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-020-00803-3

    authors: Leoncini G,Viazzi F,De Cosmo S,Russo G,Fioretto P,Pontremoli R

    更新日期:2020-10-01 00:00:00

  • Blood glucose and lipid control as risk factors in the progression of renal damage in type 2 diabetes.

    abstract::One of the central functions of the kidney is to excrete low molecular weight, water soluble, plasma, waste products into the urine, whereas macromolecules, the size of albumin and larger, are retained. The flow of the glomerular filtrate is thought to follow an extracellular route, passing through the endothelial fen...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Nosadini R,Tonolo G

    更新日期:2003-11-01 00:00:00

  • Renal cortical thickness and PON1 activity both decrease in chronic renal failure.

    abstract:BACKGROUND:Chronic renal failure (CRF) is associated with a tendency to atherosclerosis due to the enhanced oxidative stress and insufficient antioxidant enzyme activities such as superoxide dismutase (SOD), catalase (CAT) and paraoxonase (PON 1), together with abnormalities in lipid parameters. We determined the in vi...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Ak G,Ozgönül M,Sözmen EY,Aslan SL,Sözmen B

    更新日期:2002-03-01 00:00:00

  • Pericarditis in uremic patients: serum albumin and size of pericardial effusion predict drainage necessity.

    abstract:BACKGROUND:Pericardial effusion in uremic patients (UPE) was first described by R. Bright in 1836. It is generally agreed that patients require emergency pericardial drainage when tamponade signs are present, but in patients with no tamponade the optimal timing for drainage remains unclear. METHODS:To define patients ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-014-0107-7

    authors: Bataille S,Brunet P,Decourt A,Bonnet G,Loundou A,Berland Y,Habib G,Vacher-Coponat H

    更新日期:2015-02-01 00:00:00

  • The future of Diabetic Kidney Disease management: reducing the unmet need.

    abstract::Patients with type 2 diabetes run a high risk for progressive renal function loss. Many interventions have been tested to reduce the risk, but we are nowadays still confronted with a high unmet need. To improve on this unmet need, we will have to change the current strategies in drug discovery, clinical trials and cli...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-020-00820-2

    authors: de Zeeuw D

    更新日期:2020-12-01 00:00:00

  • Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.

    abstract:BACKGROUND:Early initiation of therapy is warranted for patients with idiopathic membranous nephropathy (IMN) who have severe proteinuria. Therapy with tacrolimus (TAC) or intravenous cyclophosphamide (CYC) may be an option in treating such patients. METHODS:This prospective cohort study included patients with IMN who...

    journal_title:Journal of nephrology

    pub_type: 临床试验,杂志文章

    doi:

    authors: Li X,Lv R,He Q,Li H,Du X,Lin W,Li Q,He X,Wang S,Chen J

    更新日期:2008-07-01 00:00:00

  • Thin glomerular basement membrane disease.

    abstract::The term thin glomerular basement membrane disease (TBMD) refers to a condition characterised by thinning of the GBM at electron microscopy examination and, clinically, by isolated hematuria, frequently occurring in other family members, with no extra-renal manifestations. Progression towards chronic renal failure (CR...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Frascá GM,Onetti-Muda A,Renieri A

    更新日期:2000-01-01 00:00:00

  • Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.

    abstract::It has been increasingly apparent that end-stage renal disease (ESRD) patients carry an inflammatory burden, which may play a pivotal role in the evolution of not only wasting but also of the massive increase in the relative risk of cardiovascular disease (CVD). Also increased oxidative stress (an impairment of the pr...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Maruyama Y,Lindholm B,Stenvinkel P

    更新日期:2004-11-01 00:00:00

  • Crescentic glomerulonephritis in Egypt: clinical and histopathological risk factors.

    abstract::We followed up 128 patients with crescentic glomerulonephritis (CGN), having sufficient clinical and histopathological data for a mean period of 34 +/- 28 months. There were 49 males and 79 females, mean age 22.7 +/- 14 years. We studied the effects of clinical, laboratory and histopathological parameters on kidney fu...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: El-Husseini AA,Moustafa FE,Fouda MA,Sobh MA

    更新日期:2002-05-01 00:00:00

  • Haemoglobinuria for the early identification of aHUS relapse: data from the ItalKId-HUS Network.

    abstract:BACKGROUND:Atypical haemolytic uremic syndrome (aHUS) is at high risk of relapse at any time, therefore patients require lifelong monitoring. The most appropriate way to monitor patients is not yet clear. Patients could be monitored for relapse by urine dipstick testing for haemoglobinuria based on the hypothesis that ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-021-00965-8

    authors: Brambilla M,Ardissino G,Paglialonga F,Testa S,Capone V,Montini G

    更新日期:2021-01-18 00:00:00

  • Epicardial adipose tissue: new parameter for cardiovascular risk assessment in high risk populations.

    abstract::Epicardial adipose tissue (EAT) is localized between the myocardial surface and visceral layer of the pericardium. It is a metabolically active organ that secretes several cytokines which modulate cardiovascular morphology and function. EAT may interact locally with coronary arteries through paracrine secretion mechan...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-018-0491-5

    authors: Russo R,Di Iorio B,Di Lullo L,Russo D

    更新日期:2018-12-01 00:00:00

  • Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease.

    abstract::Ferumoxytol is a new product approved for intravenous use by the US Food and Drug Administration (FDA) in the treatment of iron deficiency anemia in adults with chronic kidney disease. This approval was based on data from 3 open-label, randomized, controlled clinical trials. In all of these trials, ferumoxytol was wel...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.5301/jn.5000025

    authors: Kowalczyk M,Banach M,Rysz J

    更新日期:2011-11-01 00:00:00

  • Angioplasty of the renal artery: antihypertensive and renal effects.

    abstract::Percutaneous transluminal angioplasty of the renal artery (PTRA) has been increasingly used over the past 20 years for treating renovascular hypertension (RVH). From the experience gathered so far it is justified to state that this technique is the first choice for patients with fibromuscular renal artery stenosis (RA...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Morganti A

    更新日期:2000-11-01 00:00:00

  • Towards precision nephrology: the opportunities and challenges of genomic medicine.

    abstract::The expansion of genomic medicine is furthering our understanding of many human diseases. This is well illustrated in the field of nephrology, through the characterization, discovery, and growing insight into various renal diseases through use of Next Generation Sequencing (NGS) technologies. This review will provide ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-017-0448-0

    authors: Nestor JG,Groopman EE,Gharavi AG

    更新日期:2018-02-01 00:00:00

  • Back to the future: extended dialysis for treatment of acute kidney injury in the intensive care unit.

    abstract::On September 11, 1945, Maria Schafstaat was the first patient who successfully underwent a dialysis treatment for acute kidney injury (AKI). The ingenious design of the first dialysis machine, made of cellophane tubing wrapped around a cylinder that rotated in a bath of fluid, together with the brave determination to ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Kielstein JT,Schiffer M,Hafer C

    更新日期:2010-09-01 00:00:00

  • Membranoproliferative glomerulonephritis in a patient with Wilson's disease.

    abstract::Wilson's disease is an autosomal recessive disorder of hepatobiliary copper metabolism. Glomerular diseases can ensue during the course of Wilson's disease and membranous nephropathy is the eventual pathology in the majority of these cases. Membranoproliferative glomerulonephritis (MPGN) has rarely been reported in pa...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Ozçakar ZB,Ekim M,Ensari A,Kuloglu Z,Yüksel S,Acar B,Kirsaçlioglu C,Kansu A,Yalçinkaya F,Girgin N

    更新日期:2006-11-01 00:00:00

  • Acid-base transport in the collecting duct.

    abstract::The collecting duct is responsible for the final secretion or reabsorption of protons and bicarbonate, respectively. Approximately 2% of the total filtered bicarbonate is reabsorbed in this segment. At least two different types of cells are involved in the transport of protons and bicarbonate, namely, type A and B int...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Wagner CA,Geibel JP

    更新日期:2002-03-01 00:00:00

  • Adiponectin secreted by tubular renal cells during LPS exposure worsens the cellular inflammatory damage.

    abstract::The pathogenetic role of adiponectin (ADPN) in kidney failure is not yet elucidated, since in vitro and in vivo studies have demonstrated that ADPN exerts both anti-inflammatory and pro-inflammatory effects. Starting from our previous findings demonstrating that HK-2 cells express and secrete ADPN, in this study we in...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-015-0220-2

    authors: Perri A,Vizza D,Lupinacci S,Toteda G,De Amicis F,Leone F,Gigliotti P,Lofaro D,La Russa A,Bonofiglio R

    更新日期:2016-04-01 00:00:00

  • Arrhythmias in hemodialysis patients.

    abstract::Despite substantial progress in dialysis patients' management, cardiovascular disease remains the major cause of death. Nearly half of deaths on dialysis are secondary to myocardial infarction, cardiac arrest, malignant arrhythmias and other cardiac causes. The high prevalence of diabetes, anemia, hyperparathyroidism ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Voroneanu L,Covic A

    更新日期:2009-11-01 00:00:00

  • Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy.

    abstract:BACKGROUND:The G-1082A polymorphism of the interleukin-10 (IL-10) gene has been associated with modified gene expression and the progression of primary IgA nephropathy (IgAN). In the present study, we evaluated its influence on recurrent IgAN after renal transplantation. METHODS:We studied 103 patients who suffered fr...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Bantis C,Heering PJ,Aker S,Schwandt C,Grabensee B,Ivens K

    更新日期:2008-11-01 00:00:00

  • Renal structure in type 2 diabetes: facts and misconceptions.

    abstract::The clinical manifestations of diabetic nephropathy are similar in type 1 and type 2 diabetes, while the renal lesions may differ. Indeed, diabetic glomerulopathy is the predominant renal lesion in type 1 diabetes, although also tubular, interstitial and arteriolar lesions are present in the advanced stages of renal d...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-020-00797-y

    authors: Di Vincenzo A,Bettini S,Russo L,Mazzocut S,Mauer M,Fioretto P

    更新日期:2020-10-01 00:00:00

  • The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes.

    abstract:BACKGROUND:The endogenous inhibitor of nitric oxide synthase (NOS), asymmetric dimethylarginine (ADMA), is implicated in endothelial dysfunction and is a marker of renal disease progression and cardiovascular (CV) complications. Various cell species exhibit the enzymatic system that generates and degrades this methylar...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Spoto B,Parlongo RM,Parlongo G,Sgro' E,Zoccali C

    更新日期:2007-09-01 00:00:00